Daito Pharmaceutical Co.,Ltd.

Tokyo Stock Exchange 4577.T

Daito Pharmaceutical Co.,Ltd. EBITDA Margin for the year ending May 31, 2024: 16.89%

Daito Pharmaceutical Co.,Ltd. EBITDA Margin is 16.89% for the year ending May 31, 2024, a -16.13% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Daito Pharmaceutical Co.,Ltd. EBITDA Margin for the year ending May 31, 2023 was 20.14%, a -11.42% change year over year.
  • Daito Pharmaceutical Co.,Ltd. EBITDA Margin for the year ending May 31, 2022 was 22.73%, a 22.55% change year over year.
  • Daito Pharmaceutical Co.,Ltd. EBITDA Margin for the year ending May 31, 2021 was 18.55%, a -2.45% change year over year.
  • Daito Pharmaceutical Co.,Ltd. EBITDA Margin for the year ending May 31, 2020 was 19.02%, a 4.42% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4577.T

Daito Pharmaceutical Co.,Ltd.

Description

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.

Similar companies

4554.T

Fuji Pharma Co., Ltd.

USD 9.46

-2.05%

4530.T

Hisamitsu Pharmaceutical Co., Inc.

USD 28.70

-1.67%

4538.T

Fuso Pharmaceutical Industries,Ltd.

USD 15.69

-2.35%

4551.T

Torii Pharmaceutical Co., Ltd.

USD 32.09

-0.98%

StockViz Staff

February 2, 2025

Any question? Send us an email